+499.5%
MRNA vs ALLE
-5.8%
+505.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ALLE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.0% | -3.2% | -2.9% |
| 7D | +5.5% | -0.2% | +5.7% | +5.5% |
| 30D | +158.7% | -6.8% | +165.5% | +167.4% |
| 3M | +182.1% | +21.0% | +161.1% | +168.2% |
| 6M | +151.8% | +1.1% | +150.7% | +156.5% |
| YTD | +393.6% | -0.5% | +394.1% | +374.5% |
| 1Y | +499.5% | -7.3% | +506.7% | +524.8% |
| All | +499.5% | -5.8% | +505.3% | +524.8% |
Cumulative growth
Daily Returns
Daily percentage return beside ALLE.
Daily Out/Under-Performance
Portfolio return minus ALLE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALLE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ALLE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling